OpenAlex
PricingAboutJobs
Log inGet started
Work

Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment

HTML

Year: 2012
Type: article
Source: Current Drug Targets
DOI: 10.2174/138945012799499794
Authors: Orly Weinreb, Tamar Amit, Orit Bar-Am, Moussa B.H. Youdim
Institutions: Technion – Israel Institute of Technology, Rappaport Family Institute for Research in the Medical Sciences
Language: English

Topic: Cholinesterase and Neurodegenerative Diseases
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, Lewy body disease, acetylcholinesterase inhibition, butyrylcholinesterase inhibition, monoamine oxidase A inhibition, monoamine oxidase B inhibition, neuroprotection, APP processing, protein kinase C signaling, MAPK signaling, oxidative stress, gliosis, global cerebral ischemia, closed head injury, cerebral edema, scopolamine-induced amnesia, antidepressant safety, neurotrophic factors, mitochondrial membrane potential
SDG: Good health and well-being

Open Access status: closed

Funders: Teva Pharmaceutical Industries, Technion-Israel Institute of Technology
OpenAlex ID: W1965718249
FWCI: 7.8
Cites:
Cited by: 164
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security